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SUMMARY
The quantile approximation method has recently been proposed as a simple method for deriving conﬁdence
intervals for the treatment effect in a random effects meta-analysis. Although easily implemented, the
quantiles used to construct intervals are derived from a single simulation study. Here it is shown that
altering the study parameters, and in particular introducing changes to the distribution of the within-study
variances, can have a dramatic impact on the resulting quantiles. This is further illustrated analytically
by examining the scenario where all trials are assumed to be the same size. A more cautious approach is
therefore suggested, where the conventional standard normal quantile is used in the primary analysis, but
where the use of alternative quantiles is also considered in a sensitivity analysis. Copyright q 2008 John
Wiley & Sons, Ltd.
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1. INTRODUCTION
Meta-analysis, the statistical process of combining the results from separate trials concerned
with the same treatment or issue, is frequently used in medical statistics. A standard model for
performing meta-analyses is the random effects model and the most commonly used procedure
for implementing this is that suggested by DerSimonian and Laird [1]. Despite this it should be
noted that other approaches are possible when using this model [2–4].
The random effects model assumes that the outcome from the ith of k trials is distributed
as yi|i ∼N(i,2
i ), where i is the true underlying treatment effect for this trial and 2
i is the
corresponding within-study variance. This variance is estimated in practice, but assumed ﬁxed and
known when pooling the results, and can be obtained for a range of measures used in meta-analysis
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as described in detail by Sutton et al. [5]. This conditional distribution is justiﬁed by the Central
Limit and Slutsky’s theorems but requires sufﬁciently large trials in order to provide a suitable
approximation. The random effects model further assumes that i ∼N(,2), where  and 2
denote the overall treatment effect and between-study variance, respectively, and that the trials are
independent. This provides the marginal distributions yi ∼N(,2
i +2).
DerSimonian and Laird estimate 2 using the Q statistic,
Q=
k  
i=1
wi(yi −¯ y)2
where wi =−2
i and ¯ y=
 k
i=1wiyi/
 k
i=1wi. Evaluating E[Q] as a function of 2 and matching
this moment provides the DerSimonian and Laird estimate
ˆ 2=max
 
0,
Q−(k−1)
 k
i=1wi −
 k
i=1w2
i /
 k
i=1wi
 
If ˆ 
2 is truncated to zero then the resulting conﬁdence intervals and results from hypothesis tests are
the same as those from a ﬁxed effects analysis, which assumes from the outset that yi ∼N(,2
i ).
Hence ˆ 2=0 effectively means that a ﬁxed effects procedure is adopted, although a random effects
perspective may be maintained when interpreting the results.
Since ˆ 
2 is a consistent estimate, assuming that the number of trials is sufﬁciently large we can,
as a further approximation, replace 2 by this estimate when making inferences about the overall
treatment effect . Hence we use the model yi ∼N(,2
i +ˆ 2) for this purpose, which results in
ˆ =
 k
i=1wi(ˆ )yi
 k
i=1wi(ˆ )
where wi(ˆ )=1/(2
i +ˆ 2). The variance of this estimate is approximately var(ˆ )=1/
 k
i=1wi(ˆ )
so that a nominal 95 per cent conﬁdence interval is given by ˆ ±1.96
 
var(ˆ ). However this relies
on the notion that, approximately,
M=
ˆ −
 
var(ˆ )
∼N(0,1)
A recently proposed modiﬁcation to the approach suggested by DerSimonian and Laird is
the ‘quantile approximation method’ [6]. This ultimately follows a very similar procedure as
DerSimonian and Laird but uses an alternative set of quantiles to the usual standard normal 0.975
quantile of 1.96 when constructing 95 per cent conﬁdence intervals. These quantiles are derived
from a simulation study using parameters that correspond to ‘typical scenarios for estimating a
log odds ratio’ [6]. The resulting quantiles are all larger than 1.96 and the modiﬁcation results
in wider conﬁdence intervals with greater coverage probabilities that are intended to correspond
more closely to the nominal value than the more usual procedure achieves. A related argument
that leads to the use of larger quantiles is the observation by Follmann and Proschan [7] that if the
within-study variances are all equal, and one uses the untruncated version of the DerSimonian and
Laird estimate, the resulting test statistic has a t rather than a standard normal null distribution.
Sutton and Higgins [8, p. 628] refer to other recent studies that suggest using a t, rather than
standard normal, null distribution in the context of meta-analysis. In particular, Sidik and Jonkman
[9] suggest using a t distribution with a variety of variance estimators and emphasize that both
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the within and between-study variances are estimates. B¨ ockenhoff and Hartung [10] address the
speciﬁc issue of estimating the within-study variances, but here it will be assumed that the studies
are large enough for these to be regarded as known and that the random effects model is correct.
The problems are therefore caused by having to estimate the between-study variance, and using
this as if it was the true value, in the conventional way.
Although the quantile approximation method is intuitively appealing, a single simulation study
provides little assurance that the properties of M will be similar under alternative circumstances.
The intention of this paper is to re-assess this method. The rest of the paper is set out as follows.
In Section 2 the procedure from which the quantile approximation method was derived is brieﬂy
described, and in Section 3 some further simulation studies are performed, and analytical results
are derived, that show that the original simulation study need not provide a good indication of
the properties of M for alternative scenarios. A more cautious approach is therefore suggested,
where the usual standard normal quantile is used in the primary analysis, but the use of alternative
quantiles is considered in a secondary or sensitivity analysis. This procedure is illustrated using
an example data set in Section 4. Section 5, the discussion, concludes the paper.
2. THE QUANTILE APPROXIMATION METHOD
The quantile approximation method has been recently proposed by Brockwell and Gordon; for a
full description of this and its justiﬁcation, see their original paper [6]. In the original simulation
study, values of 2
i were simulated from a scaled and truncated 2 distribution (with one degree of
freedom, using a scale factor of 0.25 and then truncated to lie in the interval [0.009,0.6]). For each
of k=2,3,...,30, 19 values 2=0,0.01,0.02,...,0.1,0.15,0.2,...,0.5 were used, for each of
which 25000 simulated data sets were produced from the random effects model yi ∼N(,2
i +2);
=0.5 was used but this choice is immaterial. This results in 19×25000=475000 simulated
meta-analyses for each k. The random variable M=(ˆ −)/
 
var(ˆ ) was evaluated for each of
these sets of 475000 meta-analyses and the 0.025 and 0.975 quantiles, denoted by ˆ C0.025 and
ˆ C0.975, were obtained. Assuming symmetry, ˆ f (k)=1/2(− ˆ C0.025+ ˆ C0.975) provides an estimate
of the 0.975 quantile for any given k. In order to smooth the resulting quantiles, the ˆ f (k) were
regressed on 1/k,1 /
√
k and 1/log(k) and this regression curve was used to provide the quantiles
of M. Brockwell and Gordon propose that these quantiles be used when constructing 95 per cent
conﬁdence intervals, rather than the more conventional standard normal quantile of 1.96, and
tabulate these values in their Table II. Other than this change in the quantile used, the quantile
approximation method adopts the approach of DerSimonian and Laird in its entirety.
3. ADDITIONAL SIMULATION STUDIES AND ANALYTICAL RESULTS
In order to explore the applicability of the quantiles provided, two similar but slightly different
simulation studies will be performed. These use exactly the same parameter values as those utilized
by Brockwell and Gordon, except that the within-study variances will be truncated to lie in the
intervals [0.06,0.6] and [0.0009,0.6], respectively. The ﬁrst scenario is similar to the one explored
previously, but with the important difference that large (small within-study variance) trials are
not observed. Meta-analyses based on several relatively small trials are commonplace, and is the
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Figure 1. Funnel plot showing the trial sizes permitted by three alternative simulation studies.
scenario, which this simulation study attempts to imitate. Since the 2
i are simulated for every single
trial in the simulation study, 475000k within-study variances are needed for each of k=2,3,...,30,
and a very large number of within-study variances is needed in total. The variances were simulated
directly from a scaled 2
1 distribution and values that lay out of the allowable range of [0.06,0.6]
were discarded. If the range were restricted further then it would be considerably more efﬁcient
to simulate directly from the distribution of the within-study variances.
The second scenario is also similar to that assumed by Brockwell and Gordon but permits very
large ‘mega-trials’, which may occur in situations where such trials have been performed where
these are deemed necessary in order to try to obtain a deﬁnitive estimate of treatment effect.
The funnel plot shown in Figure 1 illustrates the types of trials permitted by these simulation
studies. Here 3000 within-study variances have been simulated from the scaled 2 distribution
described above, but truncated to lie within [0.0008,0.6], from which indicative yi have been
simulated from yi ∼N(0.5,2
i +0.2). Here the precision is deﬁned as 1/2
i =wi(0) and the square-
root of the precision is plotted against yi. The ﬁrst simulation study performed here only permits
small trials that lie beneath the horizontal line labelled
√
1/0.06, whereas the simulation study
performed by Brockwell and Gordon permit those that lie beneath
√
1/0.009. Finally the second
simulation performed here permits trials that lie under
√
1/0.0009 and allows very large mega
trials as shown in Figure 1. The within-study variances used in Figure 1 were truncated to lie
within [0.0008,0.6] to emphasize that even the second simulation study described above does
not permit trials of inordinate size, and the axes chosen were adopted to adequately display the
variation in the trial sizes.
The results from the simulation studies are shown in Figure 2. For the ﬁrst simulation study
the plotted points, shown as triangles, are the simulated ˆ f (k) and the corresponding curve shows
the ﬁtted regression of ˆ f (k) on k; the ﬁtted model is 1.906+0.304/k+0.774/
√
k−0.095/log(k).
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Figure 2. 97.5 per cent quantiles of M from the simulation studies. Triangles show the results for the
ﬁrst scenario, where within-study variances lie in the interval [0.06,0.6]; circles show the results for the
second scenario, where the within-study variances lie in the interval [0.0009,0.6]. The corresponding
solid curves show the ﬁtted regressions and the other solid curve follows the quantiles from the quantile
approximation method. The dashed line shows the standard normal quantile, for comparison.
The results from the second simulation study are similarly shown in Figure 2 using circles as
plotting points. Here the ﬁtted model is 1.936+4.089/k+2.069/
√
k−0.819/log(k) and much
larger quantiles result. The other solid line follows the quantiles given by Brockwell and Gordon
in their Table II, and the dashed line shows the standard normal quantile of 1.96 for comparison.
It is clear from Figure 2 that the distribution used for the within-study variances can have
considerable implications for the resulting quantiles of M. The asymptotic results that justify the
standard procedure ensure that, as k→∞, the quantiles tend towards 1.96. Regression equations
that have this limit might be considered, as the ﬁtted regression equations do not provide this and
should not be extrapolated for much larger values of k. We have not investigated this further, as
this exercise merely serves to highlight that alternative quantiles result from different scenarios,
and hence no such regression equation can give reliable quantiles for all circumstances.
3.1. Why do the simulation studies provide such different results?
The scenarios examined above were motivated by a consideration of Higgins and Thompson’s [11]
typical within-study variance, 2
t .T h i si sg i v e nb y
2
t =
(k−1)
 k
i=1wi
(
 k
i=1wi)2−
 k
i=1w2
i
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This formula applies to a ﬁnite sample of within-study variances, but in our simulation studies
we assume a population distribution for these. Taking the limit as k→∞ however provides this
population and 2
t →1/E[Wi], where E[Wi] denotes the expectation of the reciprocal of the
within-study variances. If the within-study variances are drawn from 0.252
1, and then truncated
to lie within [a,b], then the density of their reciprocal is
f (w)=
42
1(4/w)
w2 f (a,b)
for w∈[1/b,1/a] where 2
1(·) denotes the probability density function of a 2 distribution with
one degree of freedom, and f (a,b) denotes the probability that this random variable lies in the
interval [4a,4b]. Hence
E[Wi]=
  1/a
1/b
wf (w)dw
and the reciprocal of this integral gives the typical within-study variance for the population. For
the simulation study conducted by Brockwell and Gordon, this typical within-study variance is
0.056.
The ﬁrst simulation study however does not permit within-study variances less than 0.06, and
the typical within-study variance is 0.160. For the second simulation study the typical variance is
a mere 0.017. These very different typical study sizes help to explain the impact of the changes
in the procedure and the difﬁculty in generalising ﬁndings from a particular simulation study to
meta-analysis more generally, as the results depend on the value of 2 in relation to the sizes of
the studies, as demonstrated analytically in the next section.
3.2. The analytical form of M for the case where all trials are the same size
In order to further examine distribution of M, we will consider the special case where 2
i =2 for
all i, i.e. all trials are of the same ‘size’.
Under this simpliﬁcation we have that the yi are i.i.d. from a normal distribution and therefore
all the usual standard results apply. In particular the distribution of the sample mean of the yi, ¯ y,
and the corresponding sample variance, s2=
 k
i=1(yi −¯ y)2/(k−1), are related to those of well-
known distributions and are independently distributed. Furthermore, the untruncated DerSimonian
and Laird estimate of 2 has the very simple form ˆ 
2
u =s2−2. As the sample variance s2 is a
continuous random variable, and hence the probability that it takes the value 2 is precisely zero,
there are therefore two distinct possibilities for the more usual estimate ˆ 2: either this is truncated
to zero (if s2<2, so that a ﬁxed effects model is adopted) or positive and equal to ˆ 2
u (if s22).
Let E denote an indicator random variable for the event that a random effects procedure is adopted,
i.e. E =0i fˆ 
2=0a n dE =1 otherwise. We therefore have that the distribution of M is given by
f (m)=P(E =0) f (m|E =0)+{1−P(E =0)} f (m|E =1) (1)
In order to obtain the distribution of M we evaluate the three expressions on the right hand of
(1). These terms may be derived in a very similar manner as shown by Jackson [12], where the
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distribution of M, with =0, is derived under the hypothesis H0:=0. Deﬁning the incomplete
gamma function as
1(a,x)=
1
(a)
  x
0
t(a−1)exp(−t)dt
where (·) denotes the usual Gamma function, we obtain
P(E =0)=P(s2<2)=1
 
k−1
2
,
k−1
2(1+w2)
 
(2)
where w=−2. Conditioning on E =0, and noting that 2
i =2 for all i gives M=(¯ y−)/
 
2/k.
Noting that E =0 is equivalent to the event that s2<2,a n dt h a t¯ y and s2 are independent, we
obtain
f (m|E =0)=
1
√
1+w2
 
m
√
1+w2
 
(3)
where (·) denotes the standard normal density function. We show in the appendix that
f (m|E =1)= f{t,(k−1)}(m)
⎡
⎢ ⎢ ⎢
⎣
1−1
 
k
2
,
k−1+m2
2(1+w2)
 
1−1
 
k−1
2
,
k−1
2(1+w2)
 
⎤
⎥ ⎥ ⎥
⎦
(4)
where f(t,v)(·)denotesthedensityofStudent’st distributionwith v degreesoffreedom.Substituting
(2), (3) and (4) into (1) provides the required density f (m). The density of M depends only
on k and w2, and can also be expressed in terms of k and I2=2/(2+2)=w2/(1+w2),
the proportion of the variation provided by between-study variation. Higgins and Thompson [11]
deﬁne a corresponding statistic, denoted here as ˆ I2, ˆ I2=ˆ 
2/(2
t +ˆ 
2).I f2
i =2 for all i, 2
t =2
and I2 correspond to the true underlying value that Higgins and Thompson’s statistic describes.
As f (m) is an even function, for a ﬁxed k and I2 the 0.975 quantile of M can be obtained
numerically as the root of the equation
f (x)=
  x
−x
f (m)dm−0.95
and a contour plot of these quantiles is shown in Figure 3. Note that the usual procedure of
truncating ˆ 2, so that this is nonnegative, has been adopted. For the special case considered, if the
untruncated version of ˆ 2 were used, M would follow a t distribution and the quantiles tend towards
t quantiles as I2→1 in Figure 3. The quantile required is generally greater than the conventional
1.96 and for moderate k is highly sensitive to the value of I2. If the degree of heterogeneity is
mild the appropriate quantile is slightly less than the usual standard normal quantile.
The special case considered in this section illustrates that the appropriate quantile depends on
the degree of heterogeneity in relation to the size of the trials. It is therefore at the very least
extremely difﬁcult to ascertain an appropriate 0.975 quantile of M for meta-analysis in any degree
of generality, which is precisely what the quantile approximation method professes to do.
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Figure 3. 97.5 per cent quantiles of M assuming that all trials are of the same size.
3.3. A suggested procedure
With the above ﬁndings and discussion in mind, we make the following suggestion:
A primary analysis, using the conventional standard normal quantile of 1.96, is appropriate as
this value is usual and justiﬁed asymptotically. For k<30 in particular however, the simulation
studies and Figure 3 show that this may be too small in application and hence that nominal 95
per cent conﬁdence intervals can provide somewhat smaller coverage probabilities. In particular,
ˆ I2 can be evaluated as ˆ 2/(2
t +ˆ 2) and Figure 3 can then be used as a rough guide to assess if
the conventional quantile is likely to be appropriate. We further suggest computing a conﬁdence
interval for 2 [2,4,13,14], which can easily be transformed to provide a corresponding interval
for I2. A range of plausible values of I2 may then be considered when inspecting Figure 3 and
determining whether or not a secondary or sensitivity analysis is likely to be necessary.
The secondary analysis should involve a simulation study, using the observed within-study
variances for the particular meta-analysis in question, and a range of 2 that lie in the conﬁdence
interval, in order to investigate the appropriate quantile for M. We propose that the largest quantile
for M uncovered by this simulation study should be used in the secondary analysis. For example,
if a statistically signiﬁcant result is overturned by this process, then extreme caution needs to be
exercised when interpreting the primary analysis.
4. EXAMPLE: GLYCEROL FOR ACUTE STROKE
This example has previously been used by Jackson [15] and Baker and Jackson [16]. It concerns the
use of glycerol for preventing death in patients who suffer an acute stoke, and involves nine trials
with the results summarized as two by two tables. The data are shown in Table I, where yi denotes
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Table I. The glycerol data.
Trial (i) yi 2
i
10 .31 0.54
2 −0.57 0.17
30 .01 0.62
40 .38 0.24
50 .21 0.39
6 −1.11 0.16
71 .26 2.77
8 −0.20 0.09
90 .36 0.23
the log odds ratio of the ith trial and 2
i is the corresponding within-study variance, obtained in
the usual way [5]; a negative log odds ratio indicates that the use of glycerol is beneﬁcial.
The DerSimonian and Laird estimate of 2 is 0.08. Using this estimate in a conventional random
effects meta-analysis as described in Section 1 provides a 95 per cent conﬁdence interval for  of
(−0.55,0.22). The analysis is therefore inconclusive, but if this is valid it does allow us to infer
that the use of glycerol is neither particularly beneﬁcial nor harmful. A 95 per cent conﬁdence
interval for 2, using Viechtbauer’s Q-proﬁle method [14],i s(0,0.95).
The typical within-study variance is 0.25 and a 95 per cent conﬁdence interval for I2 is (0,0.79).
Since k=9, Figure 3 suggests that much larger quantiles than the standard 1.96 are plausible and
might be considered in a secondary analysis. Six simulation studies were therefore performed
using the empirical distribution of within-study variances, with 2=0, 0.2, 0.4, 0.6 and 0.8 and
0.95. These values lie within the conﬁdence interval for 2 and cover a wide range of plausible
possibilities. For each of these 2, 25000 meta-analyses involving nine trials with the 2
i shown in
Table I were simulated from the random effects model yi ∼N(,2
i +2); =0.5 was again adopted
although this choice is immaterial. Following the same procedure as before, M was computed
for each simulated meta-analysis and the 0.025 and 0.975 quantiles were used to estimate the
0.975 quantile, resulting in quantiles of 1.853, 2.252, 2.389, 2.410, 2.389 and 2.385, for 2=0,
0.2, 0.4, 0.6, 0.8 and 0.95, respectively. A worst case scenario is that a quantile of 2.410, rather
than the standard 1.96, should be used when constructing the 95 per cent conﬁdence interval for
, which means that the usual interval should be widened by around 2.410/1.96≈23 per cent.
This indicates that there is somewhat more uncertainty in the true treatment effect than the usual
procedure suggests. For comparison, the quantile approximation method [6] gives the even larger
quantile of 2.422, a value that does not seem particularly appropriate for the primary analysis for
this particular example.
5. DISCUSSION
The usual random effects model for meta-analysis makes a series of assumptions and approxima-
tions. The ﬁrst of these concerns the conditional normal distribution for yi|i with known variance.
This is a justiﬁable approximation provided that the trials are sufﬁciently large and this has been
assumed throughout.
The normal model for the random effect is hard to verify empirically with typically small
numbers of trials. In part due to the mathematical tractability of this assumption however, this is a
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fairly natural assumption to make. Assuming that the trials are independent is reasonable as they
are conducted separately.
The ﬁnal approximation, and one that is less likely to be appropriate in practice however, is the
use of 2=ˆ 2 in the conventional way. This is only justiﬁed as the number of trials becomes large
and the distribution of M may not closely follow a standard normal for the small sample sizes
frequently encountered in practice. Despite this, under the random effects model, the density of M
is not a function of : noting that Q is location invariant, ˆ 2 and therefore M can be written as a
function of the k variables i =(yi −)∼N(0,2
i +2), whose distributions do not depend on .
Sincethenumberandsizeoftrialsareclearlyknown,theonlyunknownvariablethatthedistribution
of M depends on is 2. When assuming particular values of this in the context of a sensitivity
analysis, M becomes a pivotal quantity for the remaining parameter . Hence M can be used to
construct conﬁdence intervals for the overall treatment effect using this pivotal quantity in the
way proposed, for a range of values of 2, after obtaining the appropriate quantiles approximately
from simulation. The dependency of the quantile on 2 is mentioned by Brockwell and Gordon,
who discuss a quantile approximation function g(k,2). Our simulation studies highlight that this
is also a function of the 2
i , and Figure 3 shows that g(k,2) is sensitive to the value of 2.T h e
uncertainty in this value should be taken into account when deciding which quantiles to use.
Figure 3 illustrates the scenarios where the standard normal quantile provides a poor approxi-
mation, but is no substitute for obtaining quantiles by simulation, because this ﬁgure only takes
into account the size of studies and considers a simple special case. An improvement might be to
produce a series of ﬁgures akin to Figure 3 where both an average and a measure of variability of
the study sizes is reﬂected in the quantiles plotted. These might be obtained from further calcu-
lations, if a suitable distribution of study sizes could be found, or more likely from additional
simulation studies. Deriving the exact distribution of M, in full generality, remains one of the most
important unsolved problems in meta-analysis.
Although the quantile approximation method attempts to take into account the exact distribution
of M for ﬁnite sample sizes, its ‘one size ﬁts all’ approach can be misleading. We propose that
the type of sensitivity analysis illustrated in Section 4 using the glycerol data be used in its stead.
This requires more work and attention to detail, but is relatively straightforward to implement
nonetheless.
APPENDIX A: PROOF OF EQUATION (4)
Conditioning on E =1, and noting that 2=2
i for all i, provides ˆ 2=ˆ 2
u=s2−2 and M=
(¯ y−)/
 
s2/k. A little rearrangement gives
M =
√
k(¯ y−)
√
2+2
 
s2(k−1)
(2+2)(k−1)
X1 =
√
k(¯ y−)
√
2+2 ∼N(0,1) and X2=
s2(k−1)
2+2 ∼2
k−1
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where X1 and X2 are independent. Furthermore M=X1/
√
X2/(k−1), conditional on E =1, which
is equivalent to the event that X2(k−1)/(1+w2)=c. The density f (x1,x2|E =1) is given by
f (x1) f (x2)I(x2c)/P(X2c), where I(x2c)=1i fx2c and I(x2c)=0 otherwise. Furthermore
P(X2c) is given by the complement of equation (2). Changing variables in the usual way with
M=X1/
√
X2/(k−1) and M2=X2, and integrating out M2 provides (4).
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